Reply to S. Kilickap et al, Y. Karakas et al, and I.A. Voutsadakis

Affiliations

¹ The Institute of Cancer Research, Sutton, London, United Kingdom james.morden@icr.ac.uk.
² The Institute of Cancer Research, Sutton, London, United Kingdom.

Comment

James P Morden et al. J Clin Oncol. 2016.

. 2016 Jun 10;34(17):2071-2.

doi: 10.1200/JCO.2016.66.7709. Epub 2016 Mar 21.

¹ The Institute of Cancer Research, Sutton, London, United Kingdom james.morden@icr.ac.uk.
² The Institute of Cancer Research, Sutton, London, United Kingdom.

No abstract available

Comment on

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.
Eeles RA, Morden JP, Gore M, Mansi J, Glees J, Wenczl M, Williams C, Kitchener H, Osborne R, Guthrie D, Harper P, Bliss JM. Eeles RA, et al. J Clin Oncol. 2015 Dec 10;33(35):4138-44. doi: 10.1200/JCO.2015.60.9719. Epub 2015 Sep 28. J Clin Oncol. 2015. PMID: 26417001 Clinical Trial.
On Adjuvant Hormone Therapy in Epithelial Ovarian Cancer.
Voutsadakis IA. Voutsadakis IA. J Clin Oncol. 2016 Jun 10;34(17):2070-1. doi: 10.1200/JCO.2015.66.3245. Epub 2016 Mar 21. J Clin Oncol. 2016. PMID: 27001577 No abstract available.
Does Adjuvant Hormone Therapy Improve Survival in Epithelial Ovarian Cancer?
Kilickap S, Tural D. Kilickap S, et al. J Clin Oncol. 2016 Jun 10;34(17):2069. doi: 10.1200/JCO.2015.65.3683. Epub 2016 Mar 21. J Clin Oncol. 2016. PMID: 27001584 No abstract available.
Analysis of the Adjuvant Hormone Therapy Randomized Trial.
Karakas Y, Akin S, Dizdar O, Aksoy S. Karakas Y, et al. J Clin Oncol. 2016 Jun 10;34(17):2070. doi: 10.1200/JCO.2015.65.4277. Epub 2016 Mar 21. J Clin Oncol. 2016. PMID: 27001585 No abstract available.